- Home
- FOA vs XGN Comparison
FOA vs XGN Comparison
Compare FOA & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOA
- XGN
- Stock Information
- Founded
- FOA 2013
- XGN 2002
- Country
- FOA United States
- XGN United States
- Employees
- FOA N/A
- XGN N/A
- Industry
- FOA Finance Companies
- XGN Medical Specialities
- Sector
- FOA Finance
- XGN Health Care
- Exchange
- FOA Nasdaq
- XGN Nasdaq
- Market Cap
- FOA 272.8M
- XGN 253.9M
- IPO Year
- FOA N/A
- XGN 2019
- Fundamental
- Price
- FOA $22.71
- XGN $11.89
- Analyst Decision
- FOA Buy
- XGN Strong Buy
- Analyst Count
- FOA 2
- XGN 6
- Target Price
- FOA $27.50
- XGN $12.83
- AVG Volume (30 Days)
- FOA 122.0K
- XGN 234.9K
- Earning Date
- FOA 11-04-2025
- XGN 11-04-2025
- Dividend Yield
- FOA N/A
- XGN N/A
- EPS Growth
- FOA N/A
- XGN N/A
- EPS
- FOA 7.10
- XGN N/A
- Revenue
- FOA $527,520,999.00
- XGN $58,862,000.00
- Revenue This Year
- FOA $21.21
- XGN $22.50
- Revenue Next Year
- FOA $10.95
- XGN $14.19
- P/E Ratio
- FOA $3.20
- XGN N/A
- Revenue Growth
- FOA 46.94
- XGN 3.89
- 52 Week Low
- FOA $11.33
- XGN $2.38
- 52 Week High
- FOA $32.40
- XGN $12.23
- Technical
- Relative Strength Index (RSI)
- FOA 48.19
- XGN 68.45
- Support Level
- FOA $22.38
- XGN $11.58
- Resistance Level
- FOA $23.21
- XGN $12.23
- Average True Range (ATR)
- FOA 0.83
- XGN 0.35
- MACD
- FOA 0.22
- XGN -0.01
- Stochastic Oscillator
- FOA 69.15
- XGN 76.55
About FOA Finance of America Companies Inc.
Finance of America Companies Inc is a financial services holding company that, through its operating subsidiaries, is a modern retirement solutions platform that provides customers with access to a range of retirement offerings centered on the home. In addition, FoA offers capital markets and portfolio management capabilities to optimize the distribution of its originated loans to investors. It operates through two segments: Retirement Solutions and Portfolio Management. It generates the majority of its revenue from Retirement Solutions.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.